VascVersa is new Regenerative Medicine company recently spun out from Queen's University in Belfast.
Our Vision is to commercialise living medicines to reinvigorate patients lives.
Utilising ANGICYTE technology we are developing new cell therapies for vascular regeneration.
VascVersa has a strong and committed team with both scientific and business expertise.
Dr Christina O'Neill
CEO & Founder
Dr Reinhold Medina
CSO & Founder
Professor Alan Stitt
Chair & Founder
Dr Timothy Allsopp
Business Adviser & Non Executive chair